PET Imaging with S-[11C]Methyl-L-Cysteine and L-[Methyl-11C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation

Abstract

PurposeS-[11C]-methyl-L-cysteine ([11C]MCYS) has been claimed to offer higher tumor selectivity than L-[methyl- 11C]methionine ([11C]MET). We examined this claim in animal models.ProceduresRats with implanted untreated (n = 10) or irradiated (n = 7, 1 × 25 Gy, on day 8) orthotopic gliomas were scanned after 6, 9, and 12 days, using positron emission tomography. Rats with striatal injections of saline (n = 9) or bacterial lipopolysaccharide (n = 9) were scanned after 3 days.ResultsUptake of the two tracers in untreated gliomas was similar. [11C]MCYS was not accumulated in salivary glands, nasal epithelium, and healing wounds, in contrast to [11C]MET, but showed 40 % higher accumulation in the healthy brain. Both tracers showed a reduced tumor uptake 4 days after irradiation and minor accumulation in inflamed striatum. [11C]MCYS indicated higher lesion volumes than [11C]MET (untreated tumor + 47 %; irradiated tumor up to + 500 %; LPS-inflamed striatum + 240 %).Conclusions[11C]MCYS was less accumulated in some non-tumor tissues than [11C]MET, but showed lower tumor-to-brain contrast.Electronic supplementary materialThe online version of this article (10.1007/s11307-017-1137-z) contains supplementary material, which is available to authorized users.

RETRACTED: CDKL5 promotes proliferation, migration, and chemotherapeutic drug resistance of glioma cells via activation of the PI3K/AKT signaling pathway

“…As the most prevalent cancer in the central nervous system because of the noticeable incidence rate, fast relapse and limited survival , gliomas are characterized by persistent growth, reinforced migration and invasion, and multiple molecular and cytogenetic aberrances . Standard glioma therapy consists of surgery before radiotherapy and chemotherapy . Nevertheless, drug resistance is a difficult challenge to overcome .…”

Synthesis of enantiopure 18F-trifluoromethyl cysteine as a structure-mimetic amino acid tracer for glioma imaging

“…, blood, heart, lung, pancreas, and stomach) was observed during the entire experimental process ( Figure 4B ), revealing that 2D has advantages of rapid in vivo clearance. Similar to 1L and 1D 35, 36, 39, low accumulation of 2D in the brain was found in the biodistribution data, which could be considered as an advantage or a disadvantage. It was an advantage because the tracer with low brain uptake would contribute to providing a low background activity for PET imaging of brain tumors.…”

11C-Methionine PET Identifies Astroglia Involvement in Heart–Brain Inflammation Networking After Acute Myocardial Infarction

“…Moreover, we identified expression of the L-type amino acid transporter, particularly in GFAP-positive astrocytes, suggesting that 11 C-methionine identifies an astrocyte-driven component of neuroinflammation after acute MI, which is different from the microglia component analyzed by TSPO imaging in our prior work (7). 11 C-methionine is widely used for glioma imaging and is suitable for imaging inflammatory conditions in the brain (9,16,17). We and others reported selective accumulation of 11 C-methionine by proinflammatory leukocytes within the infarct region after acute MI (10,11).…”